Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm Technologies, Tyson Foods, Clover Health Investments, and bluebird bio and Encourages Investors to Contact the Firm
February 24, 2021 19:00 ET | Source: Bragar Eagel & Squire Bragar Eagel & Squire New York, New York, UNITED STATES
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of iRhythm Technologies, Inc. (NASDAQ: IRTC), Tyson Foods, Inc. (NYSE: TSN), Clover Health Investments Corp. (NASDAQ: CLOV, CLOVW), and bluebird bio, Inc. (NASDAQ: BLUE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
RADNOR, Pa., Feb. 22, 2021 (GLOBE NEWSWIRE) The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive (the “Class Period”). Lead Plaintiff Deadline: April 2, 2021 Website:https://www.ktmc.com/irhythm-technologies-inc-securities-class-action?utm source=PR&utm medium=link&utm campaign=irhythm Contact:James Maro, Esq. (484) 270-1453 Adrienne Bell, Esq. (484) 270-1435 Toll free (844) 887-9500 According to the complaint, iRhythm is a digital healthcare company that offers a portfolio of ambulatory cardiac monitoring services on its platform called the Zio service. iRhythm receives revenue for its Zio service primar
LOS ANGELES, CA / ACCESSWIRE / February 22, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.
RADNOR, Pa., Feb. 18, 2021 (GLOBE NEWSWIRE) The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive (the “Class Period”). Investor Deadline Alert: Investors who purchased or acquired iRhythm common stock during the Class Period may, no later than April 2, 2021, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at info@ktmc.com; or click https://www.ktmc.com/irhythm-technolog
Pomerantz LLP is investigating claims on behalf of investors of iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ: IRTC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.